Consolidated Statements of Operations - USD ($)		1 Months Ended	11 Months Ended	12 Months Ended
		Jan. 23, 2018	Dec. 31, 2018	Dec. 31, 2019
Operating expenses:
Research and development			$ 848,809	$ 8,822,226
General and administrative			3,049,337	3,165,331
Total operating expenses			3,898,146	11,987,557
Loss from operations			(3,898,146)	(11,987,557)
Other income:
Interest income			55,960	117,329
Total other income			55,960	117,329
Net loss			(3,842,186)	(11,870,228)
Preferred stock dividend			(728,350)	(875,359)
Deemed dividend for beneficial conversion feature of Series A Preferred Stock				(23,929,751)
Net loss applicable to common stock			$ (4,570,536)	$ (36,675,338)
Net loss applicable to common stock per share, basic and diluted			$ (1.31)	$ (5.31)
Weighted average common shares outstanding, basic and diluted			3,483,836	6,904,983
Predecessor [Member]
Operating expenses:
Research and development	[1]
General and administrative	[1]
Total operating expenses	[1]
Loss from operations	[1]
Other income:
Interest income	[1]
Total other income	[1]
Net loss	[1]
Preferred stock dividend	[1]
Deemed dividend for beneficial conversion feature of Series A Preferred Stock	[1]
Net loss applicable to common stock	[1]
Net loss applicable to common stock per share, basic and diluted
Weighted average common shares outstanding, basic and diluted

[1] Operations were not material.